Cn /En

News Center

——

Company news

Industry news

InnoModels Biotechnology CDC In Vitro Immuno-Tumor Cell Co-Culture Killing Experimental Platform

Author:

InnoModels

Release time:

2024-04-17

With the rapid development in the field of cancer treatment, the therapeutic potential of immunotherapy, especially cytotoxic drugs (CDC), has received widespread attention. However, how to accurately assess the efficacy of CDC drugs in vivo and how to optimize the therapeutic regimen has been a challenge for researchers and pharmaceutical companies. To address this issue, InnoModels Biotechnology has developed a CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides a new powerful tool for tumor immunotherapy research.
1、Mimic the in vivo environment to accurately assess CDC drug efficacy
By simulating the interaction between immune cells and tumor cells in vivo, the CDC in vitro immune-tumor cell co-culture and killing experimental platform of InnoModels Biotechnology is able to accurately assess the efficacy of CDC drugs in an in vitro environment. The platform employs advanced cell culture technology to place immune cells and tumor cells in the same culture system to mimic the in vivo microenvironment. In such an environment, researchers can observe the effects of CDC drugs on immune cells and tumor cells to assess their efficacy.
2、Visualization of the experimental process, in-depth understanding of the immunotherapy mechanism
Compared with traditional in vitro experiments, InnoModels' CDC in vitro immune-tumor cell co-culture killing experimental platform has the characteristic of visualization. Researchers can observe the interaction between immune cells and tumor cells in real time through microscopes and other equipment, and gain an in-depth understanding of the CDC drug's mechanism of action. This visualization not only improves the accuracy of the experiment, but also helps researchers discover new treatment strategies.

3、To help new drug development and promote the progress of tumor immunotherapy
The CDC in vitro immune-tumor cell co-culture killing experimental platform of InnoModels Biotechnology is of great significance to the research and development of new drugs. Through this platform, researchers can screen potential CDC drugs, evaluate their efficacy and safety, and provide strong support for new drug development. Meanwhile, the platform can also help researchers gain a deeper understanding of the mechanism of tumor immunotherapy and provide new ideas and methods for future tumor immunotherapy.
In conclusion, InnoModels' CDC in vitro immune-tumor cell co-culture killing experimental platform brings new breakthroughs in tumor immunotherapy research. By simulating the in vivo environment, accurately assessing CDC drug efficacy, and visualizing the experimental process, the platform provides researchers with a powerful research tool. With the continuous development in the field of tumor immunotherapy, it is believed that InnoModels' CDC in vitro immune-tumor cell co-culture and killing experimental platform will play an even more important role in the future, and promote greater breakthroughs in tumor immunotherapy.

InnoModels Biotechnology: ADCC Platform Features

InnoModels Biotechnology: Immune Co-Culture Killing Models

InnoModels Biotechnology: ADCC Platform Features

InnoModels Biotechnology: Immune Co-Culture Killing Models

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License